Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
contract research organization
Manufacturing
WuXi Bio, WuXi XDC upbeat on 2025 after strong 2024 earnings
Shortly after WuXi AppTec offered an upbeat outlook for 2025, other WuXi companies are touting their own 2024 success stories and ambitions for 2025.
Fraiser Kansteiner
Mar 25, 2025 10:45am
WuXi AppTec offers rosy 2025 guidance despite US-China tensions
Mar 18, 2025 4:30pm
Syngene to pay $37M for Emergent's Baltimore biologics plant
Mar 10, 2025 3:45pm
BIOSECURE Act undermines confidence in Chinese partners: survey
Jul 2, 2024 1:42pm
WuXi Bio pulls out of 2024 BIO convention
May 1, 2024 2:48pm
BIO survey to elucidate US biopharma's reliance on Chinese CDMOs
May 1, 2024 11:00am
